These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37598860)

  • 1. Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression.
    Li CHZ; Pas JAAH; Corradi Z; Hitti-Malin RJ; Hoogstede A; Runhart EH; Dhooge PPA; Collin RWJ; Cremers FPM; Hoyng CB
    Ophthalmology; 2024 Jan; 131(1):87-97. PubMed ID: 37598860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic characteristics of late-onset Stargardt's disease.
    Westeneng-van Haaften SC; Boon CJ; Cremers FP; Hoefsloot LH; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Jun; 119(6):1199-210. PubMed ID: 22449572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foveal sparing in Stargardt disease.
    van Huet RA; Bax NM; Westeneng-Van Haaften SC; Muhamad M; Zonneveld-Vrieling MN; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7467-78. PubMed ID: 25324290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric Inter-Eye Progression in Stargardt Disease.
    Lambertus S; Bax NM; Groenewoud JM; Cremers FP; van der Wilt GJ; Klevering BJ; Theelen T; Hoyng CB
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6824-6830. PubMed ID: 28002570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset stargardt disease: phenotypic and genotypic characteristics.
    Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
    Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Disease Progression in Atrophic Age-Related Macular Degeneration and Late-Onset Stargardt Disease.
    Lindner M; Lambertus S; Mauschitz MM; Bax NM; Kersten E; Lüning A; Nadal J; Schmitz-Valckenberg S; Schmid M; Holz FG; Hoyng CB; Fleckenstein M;
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1001-1007. PubMed ID: 28288486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
    Sisk RA; Leng T
    Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, Genotypic, and Imaging Characterization of the Spectrum of ABCA4 Retinopathies.
    Romano F; Lamanna F; Boon CJF; Siligato A; Kalra G; Agarwal A; Medori C; Bertelli M; Pellegrini M; Invernizzi A; Staurenghi G; Salvetti AP
    Ophthalmol Retina; 2024 May; 8(5):509-519. PubMed ID: 37924945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular characteristics of childhood-onset Stargardt disease.
    Fujinami K; Zernant J; Chana RK; Wright GA; Tsunoda K; Ozawa Y; Tsubota K; Robson AG; Holder GE; Allikmets R; Michaelides M; Moore AT
    Ophthalmology; 2015 Feb; 122(2):326-34. PubMed ID: 25312043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Patterns of Macular Degeneration in ABCA4-Associated Retinopathy.
    Khan KN; Kasilian M; Mahroo OAR; Tanna P; Kalitzeos A; Robson AG; Tsunoda K; Iwata T; Moore AT; Fujinami K; Michaelides M
    Ophthalmology; 2018 May; 125(5):735-746. PubMed ID: 29310964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly Variable Disease Courses in Siblings with Stargardt Disease.
    Valkenburg D; Runhart EH; Bax NM; Liefers B; Lambertus SL; Sánchez CI; Cremers FPM; Hoyng CB
    Ophthalmology; 2019 Dec; 126(12):1712-1721. PubMed ID: 31522899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absence of fundus abnormalities in Stargardt disease.
    Bax NM; Lambertus S; Cremers FPM; Klevering BJ; Hoyng CB
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1147-1157. PubMed ID: 30903310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Scleral Exposure: A Degenerative Outcome of End-Stage Stargardt Disease.
    Lee W; Zernant J; Nagasaki T; Tsang SH; Allikmets R
    Am J Ophthalmol; 2018 Nov; 195():16-25. PubMed ID: 30055151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Common ABCA4 Variant p.Asn1868Ile Shows Nonpenetrance and Variable Expression of Stargardt Disease When Present in trans With Severe Variants.
    Runhart EH; Sangermano R; Cornelis SS; Verheij JBGM; Plomp AS; Boon CJF; Lugtenberg D; Roosing S; Bax NM; Blokland EAW; Jacobs-Camps MHM; van der Velde-Visser SD; Pott JR; Rohrschneider K; Thiadens AAHJ; Klaver CCW; van den Born LI; Hoyng CB; Cremers FPM
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3220-3231. PubMed ID: 29971439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of Late-Onset Stargardt Disease.
    Lambertus S; Lindner M; Bax NM; Mauschitz MM; Nadal J; Schmid M; Schmitz-Valckenberg S; den Hollander AI; Weber BH; Holz FG; van der Wilt GJ; Fleckenstein M; Hoyng CB;
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5186-5191. PubMed ID: 27699414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
    Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
    Schönbach EM; Wolfson Y; Strauss RW; Ibrahim MA; Kong X; Muñoz B; Birch DG; Cideciyan AV; Hahn GA; Nittala M; Sunness JS; Sadda SR; West SK; Scholl HPN;
    JAMA Ophthalmol; 2017 Jul; 135(7):696-703. PubMed ID: 28542693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function.
    Fujinami K; Sergouniotis PI; Davidson AE; Wright G; Chana RK; Tsunoda K; Tsubota K; Egan CA; Robson AG; Moore AT; Holder GE; Michaelides M; Webster AR
    Am J Ophthalmol; 2013 Sep; 156(3):487-501.e1. PubMed ID: 23953153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local progression kinetics of macular atrophy in recessive Stargardt disease.
    Young BK; Zhao PY; Shen LL; Fahim AT; Jayasundera KT
    Ophthalmic Genet; 2023 Dec; 44(6):539-546. PubMed ID: 37381907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular abnormalities in patients with Stargardt disease assessed with optical coherence tomography angiography.
    Battaglia Parodi M; Cicinelli MV; Rabiolo A; Pierro L; Bolognesi G; Bandello F
    Br J Ophthalmol; 2017 Jun; 101(6):780-785. PubMed ID: 27628426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.